Recent progress on small molecules targeting epigenetic complexes.

Area of Science:

• Epigenetics
• Molecular Biology
• Drug Discovery

Background:

• Historically, epigenetic drug discovery concentrated on enzymes like histone deacetylases (HDACs).
• Emerging research highlights the significance of multiprotein complexes in epigenetic regulation.
• Dysfunctional epigenetic complexes are implicated in various pathological conditions.

Purpose of the Study:

• To review small molecules targeting key epigenetic complexes.
• To focus on recent drug discovery endeavors.
• To examine complexes including Polycomb Repressive Complex 2 (PRC2), Polycomb Repressive Complex 1 (PRC1), and the CoREST complex.

Main Methods:

• Literature review of recent drug discovery studies.
• Analysis of small molecules modulating epigenetic complex function.
• Focus on PRC2, PRC1, and CoREST complex targeting strategies.

Main Results:

• Identification of emerging small molecules targeting epigenetic complexes.
• Overview of drug discovery approaches for PRC2, PRC1, and CoREST.
• Highlighting the shift towards targeting complex machinery in epigenetics.

Conclusions:

• Small molecules targeting epigenetic complexes represent a promising area in drug discovery.
• PRC2, PRC1, and CoREST complexes are key targets for therapeutic intervention.
• Further research into these complexes could yield novel treatments for epigenetic-related diseases.